Clinical trial
Phase III Randomized Study of Collagenase in Patients With Residual Stage…
NCT00014742 · State University of New York, Other · Completed
Key facts
| NCT number | NCT00014742 |
|---|---|
| Title | Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease |
| Lead sponsor | State University of New York, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dupuytren's Contracture |
| Intervention type | Drug |
| Interventions | collagenase |
| Enrollment | 72 |
| Completion | Apr 1, 2004 |
| First posted | Apr 11, 2001 |
| Last update posted | Mar 25, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: